Critical role of MicroRNA-155 in herpes simplex encephalitis

Journal of Immunology

Volumn 192, Issue 6, 2014, Pages 2734-2743

  Bhela, Siddheshvar ^a   Mulik, Sachin ^a,b   Reddy, Pradeep B J ^a   Richardson, Raphael L ^a   Gimenez, Fernanda ^a   Rajasagi, Naveen K ^a   Veiga Parga, Tamara ^a   Osmand, Alexander P ^c   Rouse, Barry T ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; MICRORNA 155;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL HOMING; CELLULAR IMMUNITY; CONTROLLED STUDY; DERMATITIS HERPETIFORMIS; EFFECTOR CELL; EYE INFECTION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS; VIRUS REACTIVATION; VIRUS REPLICATION;

ACYCLOVIR; ADOPTIVE TRANSFER; ANIMALS; ANTIVIRAL AGENTS; BRAIN; CD8-POSITIVE T-LYMPHOCYTES; ENCEPHALITIS, HERPES SIMPLEX; FEMALE; FLOW CYTOMETRY; GENETIC PREDISPOSITION TO DISEASE; HERPESVIRUS 1, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MICRORNAS; SURVIVAL ANALYSIS; VIRUS REPLICATION;

EID: 84897523967     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302326     Document Type: Article

References (47)

1. Roizman, B., D. M. Knipe, and R. Whitley. 2007. Herpes simplex viruses. In Fields Virology, 5th Ed. D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus, eds. Lippincott, Williams & Wilkins, Philadelphia, PA, p. 2501-2601.
2. Whitley, R. J. 2006. Herpes simplex encephalitis: adolescents and adults. Antiviral Res. 71: 141-148.
3. Zhang, S. Y., E. Jouanguy, S. Ugolini, A. Smahi, G. Elain, P. Romero, D. Segal, V. Sancho-Shimizu, L. Lorenzo, A. Puel, et al. 2007. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317: 1522-1527.
4. Guo, Y., M. Audry, M. Ciancanelli, L. Alsina, J. Azevedo, M. Herman, E. Anguiano, V. Sancho-Shimizu, L. Lorenzo, E. Pauwels, et al. 2011. Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J. Exp. Med. 208: 2083-2098.
5. Zhang, S. Y., M. Herman, M. J. Ciancanelli, R. Pérez de Diego, V. Sancho-Shimizu, L. Abel, and J. L. Casanova. 2013. TLR3 immunity to infection in mice and humans. Curr. Opin. Immunol. 25: 19-33.
6. Whitley, R. J. 1990. Herpes simplex viruses. In Fields Virology. B. N. Fields, P. M. Howley, eds. Lippincott-Raven, Philadelphia, PA, p. 1843-1845.
7. Wang, J. P., G. N. Bowen, S. Zhou, A. Cerny, A. Zacharia, D. M. Knipe, R. W. Finberg, and E. A. Kurt-Jones. 2012. Role of specific innate immune responses in herpes simplex virus infection of the central nervous system. J. Virol. 86: 2273-2281.
8. Kurt-Jones, E. A., M. Chan, S. Zhou, J. Wang, G. Reed, R. Bronson, M. M. Arnold, D. M. Knipe, and R. W. Finberg. 2004. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. USA 101: 1315-1320.
9. Lundberg, P., C. Ramakrishna, J. Brown, J. M. Tyszka, M. Hamamura, D. R. Hinton, S. Kovats, O. Nalcioglu, K. Weinberg, H. Openshaw, and E. M. Cantin. 2008. The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J. Virol. 82: 7078-7088.
10. Mulik, S., S. Bhela, and B. T. Rouse. 2013. Potential function of miRNAs in herpetic stromal keratitis. Invest. Ophthalmol. Vis. Sci. 54: 563-573.
11. O'Connell, R. M., D. S. Rao, and D. Baltimore. 2012. microRNA regulation of inflammatory responses. Annu. Rev. Immunol. 30: 295-312.
12. O'Connell, R. M., D. Kahn, W. S. Gibson, J. L. Round, R. L. Scholz, A. A. Chaudhuri, M. E. Kahn, D. S. Rao, and D. Baltimore. 2010. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33: 607-619.
13. Murugaiyan, G., V. Beynon, A. Mittal, N. Joller, and H. L. Weiner. 2011. Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 187: 2213-2221.
14. Kurowska-Stolarska, M., S. Alivernini, L. E. Ballantine, D. L. Asquith, N. L. Millar, D. S. Gilchrist, J. Reilly, M. Ierna, A. R. Fraser, B. Stolarski, et al. 2011. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc. Natl. Acad. Sci. USA 108: 11193-11198.
15. Blüml, S., M. Bonelli, B. Niederreiter, A. Puchner, G. Mayr, S. Hayer, M. I. Koenders, W. B. van den Berg, J. Smolen, and K. Redlich. 2011. Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice. Arthritis Rheum. 63: 1281-1288.
16. Simmons, A., and A. A. Nash. 1984. Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. J. Virol. 52: 816-821.
17. Osmand, A. P., V. Berthelier, and R. Wetzel. 2006. Imaging polyglutamine deposits in brain tissue. Methods Enzymol. 412: 106-122.
18. Hoffman, G. E., W.W. Le, and L. V. Sita. 2008. The importance of titrating antibodies for immunocytochemical methods. Curr. Protoc. Neurosci. Chapter 2: Unit 2.12.
19. Llewellyn-Smith, I. J., J. B. Minson, and P. M. Pilowsky. 1992. Retrograde tracing with cholera toxin B-gold or with immunocytochemically detected cholera toxin B in central nervous system. In Methods in Neurosciences, Vol. 8. P.M. Conn, ed. Academic Press, San Diego, p. 180-201.
20. Liu, T., K. M. Khanna, X. Chen, D. J. Fink, and R. L. Hendricks. 2000. CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J. Exp. Med. 191: 1459-1466.
21. Reddy, P. B., S. Sehrawat, A. Suryawanshi, N. K. Rajasagi, S. Mulik, M. Hirashima, and B. T. Rouse. 2011. Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. J. Immunol. 187: 5745-5755.
22. Sehrawat, S., P. B. Reddy, N. Rajasagi, A. Suryawanshi, M. Hirashima, and B. T. Rouse. 2010. Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. PLoS Pathog. 6: e1000882.
23. van Lint, A., M. Ayers, A. G. Brooks, R. M. Coles, W. R. Heath, and F. R. Carbone. 2004. Herpes simplex virus-specific CD8+ T cells can clear established lytic infections from skin and nerves and can partially limit the early spread of virus after cutaneous inoculation. J. Immunol. 172: 392-397.
24. Mulik, S., J. Xu, P. B. Reddy, N. K. Rajasagi, F. Gimenez, S. Sharma, P. Y. Lu, and B. T. Rouse. 2012. Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus. Am. J. Pathol. 181: 525-534.
25. Lopez, C. 1975. Genetics of natural resistance to herpesvirus infections in mice. Nature 258: 152-153.
26. Biswas, P. S., and B. T. Rouse. 2005. Early events in HSV keratitis-setting the stage for a blinding disease. Microbes Infect. 7: 799-810.
27. Coles, R. M., S. N. Mueller, W. R. Heath, F. R. Carbone, and A. G. Brooks. 2002. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1. J. Immunol. 168: 834-838.
28. Pfizenmaier, K., H. Jung, A. Starzinski-Powitz, M. Röllinghoff, and H. Wagner. 1977. The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes. J. Immunol. 119: 939-944.
29. Banerjee, K., P. S. Biswas, U. Kumaraguru, S. P. Schoenberger, and B. T. Rouse. 2004. Protective and pathological roles of virus-specific and bystander CD8+ T cells in herpetic stromal keratitis. J. Immunol. 173: 7575-7583.
30. Lang, A., and J. Nikolich-Zugich. 2005. Development and migration of protective CD8+ T cells into the nervous system following ocular herpes simplex virus-1 infection. J. Immunol. 174: 2919-2925.
31. Gebhardt, T., P. G. Whitney, A. Zaid, L. K. Mackay, A. G. Brooks, W. R. Heath, F. R. Carbone, and S. N. Mueller. 2011. Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature 477: 216-219.
32. Dudda, J. C., B. Salaun, Y. Ji, D. C. Palmer, G. C. Monnot, E. Merck, C. Boudousquie, D. T. Utzschneider, T. M. Escobar, R. Perret, et al. 2013. MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer. Immunity 38: 742-753.
33. Gracias, D. T., E. Stelekati, J. L. Hope, A. C. Boesteanu, T. A. Doering, J. Norton, Y. M. Mueller, J. A. Fraietta, E. J. Wherry, M. Turner, and P. D. Katsikis. 2013. The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling. Nat. Immunol. 14: 593-602.
34. Lind, E. F., A. R. Elford, and P. S. Ohashi. 2013. Micro-RNA 155 is required for optimal CD8+ T cell responses to acute viral and intracellular bacterial challenges. J. Immunol. 190: 1210-1216.
35. Huffaker, T. B., R. Hu, M. C. Runtsch, E. Bake, X. Chen, J. Zhao, J. L. Round, D. Baltimore, and R. M. O'Connell. 2012. Epistasis between microRNAs 155 and 146a during T cell-mediated antitumor immunity. Cell Rep. 2: 1697-1709.
36. Brocke, S., C. Piercy, L. Steinman, I. L. Weissman, and T. Veromaa. 1999. Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc. Natl. Acad. Sci. USA 96: 6896-6901.
37. Irani, D. N., and D. E. Griffin. 1996. Regulation of lymphocyte homing into the brain during viral encephalitis at various stages of infection. J. Immunol. 156: 3850-3857.
38. Adler, H., J. L. Beland, N. C. Del-Pan, L. Kobzik, R. A. Sobel, and I. J. Rimm. 1999. In the absence of T cells, natural killer cells protect from mortality due to HSV-1 encephalitis. J. Neuroimmunol. 93: 208-213.
39. Wang, P., J. Hou, L. Lin, C. Wang, X. Liu, D. Li, F. Ma, Z. Wang, and X. Cao. 2010. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J. Immunol. 185: 6226-6233.
40. Zawislak, C. L., A. M. Beaulieu, G. B. Loeb, J. Karo, D. Canner, N. A. Bezman, L. L. Lanier, A. Y. Rudensky, and J. C. Sun. 2013. Stage-specific regulation of natural killer cell homeostasis and response against viral infection by micro-RNA-155. Proc. Natl. Acad. Sci. USA 110: 6967-6972.
41. Knickelbein, J. E., K. M. Khanna, M. B. Yee, C. J. Baty, P. R. Kinchington, and R. L. Hendricks. 2008. Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science 322: 268-271.
42. Decman, V., P. R. Kinchington, S. A. Harvey, and R. L. Hendricks. 2005. Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression. J. Virol. 79: 10339-10347.
43. Rajasagi, N. K., S. H. Kassim, C. M. Kollias, X. Zhao, R. Chervenak, and S. R. Jennings. 2009. CD4+ T cells are required for the priming of CD8+ T cells following infection with herpes simplex virus type 1. J. Virol. 83: 5256-5268.
44. Nakanishi, Y., B. Lu, C. Gerard, and A. Iwasaki. 2009. CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature 462: 510-513.
45. Cardoso, A. L., J. R. Guedes, L. Pereira de Almeida, and M. C. Pedroso de Lima. 2012. miR-155 modulates microglia-mediated immune response by downregulating SOCS-1 and promoting cytokine and nitric oxide production. Immunology 135: 73-88.
46. Ponomarev, E. D., T. Veremeyko, and H. L. Weiner. 2013. MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia 61: 91-103.
47. Zheng, Y., S. Xiong, P. Jiang, R. Liu, X. Liu, J. Qian, X. Zheng, and Y. Chu. 2012. Glucocorticoids inhibit lipopolysaccharide-mediated inflammatory response by downregulating microRNA-155: a novel anti-inflammation mechanism. Free Radic. Biol. Med. 52: 1307-1317.